Company

The origins of b2Quant date back to late 2015, when the need to include quantitative brain image analysis in the follow-up of multiple sclerosis patients led to an MSc thesis at Hospital Egas Moniz, in Lisbon, Portugal. The software pipeline that resulted from that work received awards by the Portuguese Multiple Sclerosis Study Group 2017 Spring Meeting and the Fraunhofer Portugal Challenge 2017 edition. Motivated by the success of this project, a young, work-driven and highly motivated team of engineers with different areas of expertise was composed. Our goal is to explore and extend the influence of quantitative image analysis in the clinical setting, specially in diseases which heavily rely on image follow-up. Passionate about bringing innovation to the MedTech market, we have been collaborating with experienced neurologists and neuroradiologists in the development of reliable and valuable solutions.
It has been quite a journey!


Partners